Navigation Links
2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer
Date:2/4/2008

liquid formulations and solid dosages (for example eye drops and tablets), which ideally complement - and can be combined with - Gerresheimer's product range. The Group's existing product portfolio in the field of plastic packaging, which has so far been marketed primarily in Europe, will as a result increasingly find its way into the South American pharmaceutical markets.

Allplas currently achieves annual sales equivalent to around EUR16m. The EBITDA margin is 16%, which will be continuously improved in the years ahead. Integration in the Gerresheimer Group is to be completed by mid-2008. Like EDP, Allplas will become part of Gerresheimer Plastic Packaging, which specialises in pharmaceutical primary packaging and application systems under leading trade­marks such as Duma(R), Dudek(TM) and EDP(TM). Together with the two acquisitions, Gerresheimer's plastic operations achieve a total annual sales volume of around EUR350m, of which around EUR100m is attributable to the plastic packaging segment.

About Gerresheimer

Including the two acquisitions, Gerresheimer employs more than 10,800 people in forty locations in Europe, America and Asia. In the financial year 2007, worldwide sales totalled EUR957.7m. The product portfolio ranges from pharmaceutical vials made of glass and plastic to complex drug-delivery systems for the pharma and life-science industry. These include sterile syringes, inhalers and other system solutions for secure dosage and application of medications. The Group enjoys a leading position in a market which is characterised by high technical and regulatory barriers. Gerresheimer's products are subject to extremely rigorous quality requirements stipulated by the international pharmaceutical supervision authorities.

Press Dates

Annual Press Conference February 26 2008

Annual General Meeting April 17, 2008

Contact:

Burkhard Lingenberg

Director Corporate PR & Marketing

<
'/>"/>
SOURCE Gerresheimer AG
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
2. Signalife Receives Another $3.3 Million Sales Orders
3. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
4. CryoLife Announces Record Preservation Services and Product Revenues for 2007
5. Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results
6. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
7. Millennium Ships and Records the First $200,000 of Revenue Generated From the Five-Year $20,000,000 Exclusive Purchase Order
8. Protalix BioTherapeutics Sets Record Date for Annual Meeting of Shareholders
9. Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device
10. The Female Health Company Reports Record Profit for Both Fourth Quarter and Fiscal Year 2007
11. KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Mechanicsburg, Pa (PRWEB) May 20, 2013 ... controller with ramp/soak capabilities. The 5R6-900 benchtop controller ... enclosure, the device can be plugged into the wall ... own power supply. This distinctive detail makes the device ... , The laboratory temperature controller can also be ...
(Date:5/20/2013)... 20, 2013  (PSHR) Pacific Shore Holdings, Inc. ... across a broad range of product categories lines, ... relations firm, BlueWater Advisory Group, to provide strategic ... process, and to direct the company,s outreach and ... Matthew Mills , Pacific Shore ...
(Date:5/20/2013)... 20, 2013 With bed bugs' presence come ... although bed bugs need to be eliminated, one must make ... a person's health. And so to help bed bug sufferers ... get rid of bed bugs without using harmful pesticides. ... spray it called Bed Bug Bully. , According to My ...
(Date:5/20/2013)... , May 20, 2013   Flexion Therapeutics , ... W. Driscoll to its management team as ... years of financial management experience with biotechnology and medical ... Driscoll was chief financial officer for Novavax (NASDAQ: ... secured more than $250 million through a combination of ...
Breaking Biology Technology:New Laboratory Temperature Controller by Oven Industries 2Pacific Shore Holdings Retains Investor Relations Firm 2New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2
... BUCHS/AARAU, Switzerland, Feb. 2, 2012 Swisslog and JBT ... and manufacture state-of-the-art AGVs for hospitals. ... be jointly developed and marketed from 2013 onwards. The ... of logistics solutions for hospitals. JBT will supply all ...
... of the incredible strength of spider silk, the robust ... webs survive multiple tears and winds that exceed hurricane ... of spider webs with complex computer simulations has shown ... but on how the overall web design compensates for ...
... N.J., Feb. 1, 2012 Unigene Laboratories, Inc. ... the 2012 Drug Delivery Partnerships™ ("DDP") Innovation Award in ... 2011 clinical advances in the oral delivery of peptides.  ... voted on and selected by conference attendees, including leading ...
Cached Biology Technology:JBT Corporation and Swisslog Enter Into Partnership for Automated Guided Vehicles 2JBT Corporation and Swisslog Enter Into Partnership for Automated Guided Vehicles 3A spider web's strength lies in more than its silk 2A spider web's strength lies in more than its silk 3A spider web's strength lies in more than its silk 4Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award 2Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award 3Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award 4Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award 5
(Date:5/20/2013)... MINNEAPOLIS/ST. PAUL (MAY 20, 2013) University of Minnesota ... of Minnesota, in partnership with the University,s Brain Tumor ... peripheral nerve sheath tumors (MPNST) that allow them to ... of cancer. , The research was published this week ... the Sleeping Beauty transposon method, researchers in the lab ...
(Date:5/20/2013)... Science Foundation (NSF) planning grant will help establish the ... program of the University of Illinois at Urbana-Champaign and ... will be devoted to research in drying moist, porous ... and paper products; chemical products; textiles; and biopharmaceuticals," said ... science and human nutrition and the Illinois site director. ...
(Date:5/19/2013)... women of European descent inherit common foot disorders, such ... hammer or claw toe. Findings from the Framingham Foot ... in humansappear in Arthritis Care & Research , ... American College of Rheumatology (ACR). , Previous studies ... have foot disorders which may limit mobility and reduce ...
Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2NSF approves planning grant for Center for Advanced Research in Drying 2Blame your parents for bunion woes 2
... her search to understand one of the most basic human ... becoming one of the best studied model systems in neuroscience: ... professor of biomedical engineering and mechanical engineering in the McCormick ... the rat whisker system as a model to understand how ...
... DIEGO, Feb. 18, 2011 Zimmer Holdings, Inc. (NYSE: ... in musculoskeletal care, today announced that results from a ... performed using the DeNovo® NT Graft for ... two-year patient outcome measures and 21-month follow-up MRI data. ...
... 2011 A research group led by a New York ... allows a fish in the Hudson River to live in ... the February 18, 2011, online issue of Science , ... evolved rapidly in response to the toxic chemicals, which were ...
Cached Biology News:What a rat can tell us about touch 2What a rat can tell us about touch 3Clinical Benefits of Zimmer's DeNovo® NT Natural Tissue Graft in First Surgery Documented in Peer-Reviewed Publication 2Clinical Benefits of Zimmer's DeNovo® NT Natural Tissue Graft in First Surgery Documented in Peer-Reviewed Publication 3A genetic mutation allows Hudson River fish to adapt to PCBs 2
Request Info...
... Mch3 Lyophilized solid. ... regulation and kinetics, cleavage of target substrates, and inhibitor ... One unit is defined as the amount ... Cat. No. 235400 per hour at 37 C at ...
... Cytokeratin 5 / 6 Cytokeratin 5 ... basic type of cytokeratin expressed in basal, ... of stratified epithelia as well as transitional ... and mesothelioma. Cytokeratin 6 (56 kD) is ...
Bovine Coronary Artery Smooth Muscle Cells (BCASMC) (>500,000 cells)...
Biology Products: